In an observational study carried out in 85 IBDs patients, Rahier et al. [38] assessed the clinical characteristics, risk factors, and outcomes of psoriatic and eczematous lesions induced by anti-TNF-α in patients with IBD. The gene discussed is TNF; the disease is inflammatory bowel disease.